The role of plasma thiol compounds and antioxidant vitamins in patients with cardiovascular diseases

Clinica Chimica Acta

Volumn 338, Issue 1-2, 2003, Pages 99-105

  Yardim Akaydin, Sevgi ^a   Özkan, Yeşim ^a   Özkan, Ersin ^a   Torun, Meral ^a   Şimşek, Bolkan ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Antioxidant vitamins; Cardiovascular disease; Cysteine; Homocysteine; Thiol compounds

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CYSTEINE; HOMOCYSTEINE; RETINOL; THIOL DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; POPULATION RESEARCH; PRIORITY JOURNAL;

LETHRINIDAE;

EID: 0344082202     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2003.07.021     Document Type: Article

References (46)

1. Andersson A., Isaksson A., Brattstörm L., Hultberg B. Thiols as a mojor of plasma redox status in healthy subjects and in patients with renal or liver failure. Clin. Chem. 45:1999;1084-1086.
2. Maxwell S.R.J. Coronary artery disease-free radical damage, antioxidant protection and the role of homocysteine. Basic Res. Cardiol., Suppl. 95:2000;65-71.
3. Blum A., Lupovitch S., Khazim K., Peleg A., Gumanovsky M., Yeganeh S.et al. Homocysteine levels in patients with risk factors for atherosclerosis. Clin. Cardiol. 24:2001;463-466.
4. Cavalca V., Cighetti G., Bamonti F., Loaldi A., Bortone L., Novembrino C.et al. Oxidative stress and homocysteine in coronary artery disease. Clin. Chem. 47:2001;887-892.
5. McCully K.S. Homocysteine theory of atherosclerosis; development and current status. Arterioscler. Rev. 11:1983;157-246.
6. Starkebaum G., Harlan J.M. Endothelial cell injury due to copper-catalysed hydrogen peroxide generation from homocysteine. J. Clin. Invest. 77:1986;1370-1376.
7. Stamler J.S., Slivka A. Biological chemistry of thiols in the vasculature and in vascular-related disease. Nutr. Rev. 54:1996;1-30.
8. Hogg N. The effect of cyst(e)ine on the autooxidation of homocysteine. Free Radic. Biol. Med. 27:1999;28-33.
9. Wattanapitayakul S.K., Bauer J.A. Oxidative pathways in cardiovascular disease: roles, mechanisms, and therapeutic implications. Pharmacol. Ther. 89:2001;187-206.
10. Parthasarathy S. Oxidation of low density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor. Biochim. Biophys. Acta. 917:1987;337-340.
11. Gerster H. Potential role of beta-carotene in the prevention of cardiovascular disease. Int. J. Vitam. Nutr. Res. 61:1991;277-291.
12. Jialal I., Grundy S.M. Influence of antioxidant vitamins on LDL oxidation. Ann. N. Y. Acad. Sci. 669:1992;237-247.
13. Retsky K.L., Freeman M.W., Frei B. Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. Anti-rather than prooxidant activity of vitamin C in the presence of transition metal ions. J. Biol. Chem. 268:1993;1304-1309.
14. Frei B. Cardiovascular disease and nutrient antioxidants: role of low-density lipoprotein oxidation. Crit. Rev. Food Sci. Nutr. 35:1995;83-98.
15. Vester B., Rasmussen K. High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum. Eur. J. Clin. Chem. Clin. Biochem. 29:1991;549-554.
16. Lee B.L., Chua S.C., Ong H.Y., Ong C.N. High-performance liquid chromatographic method for routine determination of vitamins A and E and β-carotene in plasma. J. Chromatogr. B. 581:1992;41-47.
17. Hatch L.L., Sevanian A. Measurement of uric acid, ascorbic acid, and related metabolites in biological fluids. Anal. Biochem. 138:1984;324-328.
18. Özkan Y., Özkan E., Şimşek B. Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease. Int. J. Cardiol. 82:2002;269-277.
19. 12, and folate. Am. J. Epidemiol. 143:1996;845-859.
20. Mills B.J., Weiss M.M., Lang C.A., Liu M.C., Ziegler C. Blood glutathione and cysteine changes in cardiovascular disease. J. Lab. Clin. Med. 135:2000;396-401.
21. El-Khairy L., Vollset S.E., Refsum H., Ueland P.M. Predictors of change in plasma total cysteine: longitudinal findings from the Hordaland homocysteine study. Clin. Chem. 49:2003;113-120.
22. Chan S.J., Chang C.N., Hsu J.C., Lee Y.S., Shen C.H. Homocysteine, vitamin B6, and lipid in cardiovascular disease. Nutrition. 18:2002;595-598.
23. El-Khairy L., Ueland P.M., Refsum H., Graham I.M., Vollset S.E. Plasma total cysteine as a risk factor for vascular disease: the European concerted action project. Circulation. 103:2001;2544-2549.
24. Nordstrom M., Kjellstrom T. Age dependency of cystathionine beta-synthase activity in human fibro-blasts in homocysteinemia and atherosclerotic vascular disease. Atherosclerosis. 94:1992;213-221.
25. Selhub J., Jacques P.F., Wilson P.W.F., Rush D., Rosenberg I.H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 270:1993;2693-2699.
26. Wilcken D.E.L., Gupta V.J. Sulphur containing amino acids in chronic renal failure with particular reference to homocysteine mixed disulphide. Eur. J. Clin. Invest. 9:1997;301-307.
27. Starkebaum G., Harlan J.M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J. Clin. Invest. 77:1986;1370-1376.
28. Elliott T.G., Barth J.D., Mancini G.B. Effects of vitamin E on endothelial function in men after miyocardial infarction. Am. J. Cardiol. 76:1995;1188-1190.
29. Chowienczyk P.J., Kneale B.J., Brett S.E., Paganga G., Jenkins B.S., Ritter J.M. Lack of effect of vitamin E on L-arginine responsive endothelial dysfunction in patients with mild hypercholesterolaemia and coronary artery disease. Clin. Sci. (Colch). 94:1998;129-134.
30. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after miyocardial infarction: results of the GISSI prevenzione trial. Lancet. 354:1999;447-455.
31. The Heart Outcomes Prevention Evaluation Study Investigators Vitamin E supplementation and cardiovascular events in high-risk patients. N. Engl. J. Med. 342:2000;154-160.
32. Gaziano J.M., Manson J.E., Buring J.E., Hennekens C.H. Dietary antioxidants and cardiovascular disease. Ann. N. Y. Acad. Sci. 669:1992;249-258.
33. Gaziano J.M., Hennekens C.H. The role of beta-carotene in the prevention of cardiovascular disease. Ann. N. Y. Acad. Sci. 691:1993;148-155.
34. Kontush A., Spranger T., Reich A., Baum K., Beisiegel U. Lipophilic antioxidants in blood plasma as markers of atherosclerosis: the role of alpha-carotene and gamma-tocopherol. Atherosclerosis. 144:1999;117-122.
35. Kok F.J., De Bruidjn A.M., Vermeeren R., Hofman A., Van Laar A., de Bruin M.et al. Serum selenium, vitamin antioxidants and cardiovascular mortality: a 9-year follow-up study in the Netherlands. Am. J. Clin. Nutr. 45:1987;462-468.
36. Vita J.A., Keaney J.J., Raby K.E., Morrow J.D., Freedman J.E., Lynch S. et al. Low plasma ascorbic acid independently predicts the presence of an unstable coronary syndrome. J. Am. Coll. Cardiol. 31:1998;980-986.
37. Torun M., Yardim S., Sargin H., Şimşek B. Evaluation of serum β-carotene levels in patients with cardiovascular diseases. J. Clin. Pharm. Ther. 19:1994;61-63.
38. Hladovech J., Sommerová Z., Písaříková A. Homocysteinemia and endothelial damage after methionine load. Thromb. Res. 88:1997;361-364.
39. Brude I.R., Finstad H.S., Seljeflot I., Drevon C.A., Solvoll K., Sandstad B.et al. Plasma homocysteine concentration related to diet, endothelial function and mononuclear cell gene expression among male hyperlipidaemic smokers. Eur. J. Clin. Invest. 29:1999;100-108.
40. Nappo F., De Rosa N., Marfella R., De Lucia D., Ingrosso D., Perna A.F. et al. Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA. 281:1999;2113-2118.
41. Bunout D., Garrido A., Suazo M., Kauffman R., Venegas P., De la Maza P. et al. Effects of supplementation with folic acid and antioxidant vitamins on homocysteine levels and LDL oxidation in coronary patients. Nutrition. 16:2000;107-110.
42. Title L.M., Cummings P.M., Giddens K., Genest J.J., Nassar B.A. Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease. J. Am. Coll. Cardiol. 36:2000;758-765.
43. Hornig B., Arakawa N., Kohler C., Drexler H. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation. 97:1998;363-368.
44. Hirashima O., Kawano H., Motoyama T., Hirai N., Ohgushi M., Kugiyama K. et al. Improvement of endothelial function and insulin sensitivity with vitamin C in patients with coronary spastic angina: possible role of reactive oxygen species. J. Am. Coll. Cardiol. 35:2000;1860-1866.
45. Chambers J.C., McGregor A., Jean-Marie J., Obeid O.A., Kooner J.S. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy. Circulation. 99:1999;1156-1160.
46. Kanani P.M., Sinkey C.A., Browning R.L., Allaman M., Knapp H.R., Haynes W.G. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation. 100:1999;1161-1168.